DentalJect Selected as 2026 ADA Forsyth dentech Winner.
This recognition from the industry’s most forward-looking audience will help accelerate our conversations with dentists
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
BOCA RATON, FL, UNITED STATES, November 9, 2026 /EINPresswire.com/ — Boca Raton, FL — 11.3.26 — DentalJect Topical Anesthetic Spray from VCS Medical was named a winner in the ADA Forsyth dentech 2026 new technology competition which showcases new ideas in oral health. The competition featured 10 finalists selected to present oral health technologies to a panel of judges, who named DentalJect the top post-revenue company.
DentalJect is an FDA-cleared, drug-free topical anesthetic spray. Its targeted application numbs the oral mucosa in under 2 seconds, allowing the clinician to inject both instantly and comfortably without the use of topical drugs. Designed to fit into existing injection techniques, DentalJect can be used throughout the oral cavity, including sensitive sites like the palate, while helping streamline chairside workflow and ensuring patient recall.
“Winning Best Post-Revenue innovative dental technology at ADA Forsyth’s dentech conference validates what our customers already tell us every day: injection pain and anxiety are among the biggest barriers between patients and the care they need. This recognition from the industry’s most forward-looking audience will help accelerate our conversations with dentists who want to make a significant difference in patient comfort and care,” said Ethan Mandelup, CEO.
ADA Forsyth dentech brings together leaders in oral health, research, business and investment to explore innovation across the dental field. The 2026 conference took place September 24–25 at the ADA Forsyth Institute in Somerville, Massachusetts.
About VCS Medical
VCS Medical is on a mission to eliminate injection pain, anxiety, and fear. The company develops innovative, non-invasive anesthetic technologies designed to reduce discomfort, enhance clinical efficiency, and elevate the standard of patient care. VCS Medical envisions a future where fear of injections is a thing of the past and every patient experience is built on comfort, confidence, and optimal care.
Bill Poulson
VCS Medical
+1 844-827-3685
info@dentalject.com
Visit us on social media:
LinkedIn
Instagram
Facebook
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery
